Axios

@axios ↗

Deleted No

Hibernated Yes

Last Checked Oct. 26, 2022

Created

Fri Sep 02 18:44:11 +0000 2022

Likes

Retweets

Source

Twitter Web App

View Raw Data

JSON Data

View on Twitter

Likely Available

Axios @axios

Beyond the Pfizer study requested by the FDA, a clinical trial of immunocompromised people is evaluating if Paxlovid should be used for five, 10 or 15 days. https://t.co/fxiAnLSFZh — PolitiTweet.org

Posted Sept. 2, 2022 Hibernated

Preceded By

Axios @axios

Research in Clinical Infectious Diseases found the drug remains effective for vaccinated people who contract COVID-19, reducing emergency room visits by lowering the risk of complications like lower respiratory tract infection and cardiac arrhythmia. https://t.co/fxiAnLSFZh — PolitiTweet.org

Posted Sept. 2, 2022 Hibernated

Followed By

Axios @axios

Paxlovid remains an important tool to keep some people out of the hospitals, especially with the highly contagious Omicron variant still circulating and many people not staying current on boosters, experts said. https://t.co/fxiAnLSFZh — PolitiTweet.org

Posted Sept. 2, 2022 Hibernated